Cyclin-dependent kinase inhibitor 2A/B (CDKN2A/B) is an important regulator of cell growth regulation and apoptosis, while the absence of cell proliferation regulation and cell cycle regulation is crucial for the development and progression of cancer (Hayward et al. 2017; Kathiravan et al. 2019). This evidence concerns the gene CDKN2A and cancer.